Indo Us Bio-Tech Limited (NSE:INDOUS)
India · Delayed Price · Currency is INR 91.21
+1.55 (1.73%)
Jun 19, 2026, 3:30 PM IST
Indo Us Bio-Tech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 131.23 | 162.67 | 82.41 | 72.4 | 50.63 |
Depreciation & Amortization | 9.02 | 10.98 | 8 | 8.26 | 4.46 |
Other Amortization | - | - | - | - | 0.14 |
Loss (Gain) From Sale of Assets | -0.01 | - | 0.04 | - | - |
Provision & Write-off of Bad Debts | 3.05 | 4.68 | -0.6 | - | - |
Other Operating Activities | 26.57 | 13.42 | 17.55 | 10.23 | 10.4 |
Change in Accounts Receivable | 9.38 | 35.76 | 57.57 | -42.01 | 41.59 |
Change in Inventory | -292.67 | -189.51 | -248.22 | -35.56 | -114.77 |
Change in Accounts Payable | -6.62 | -32.26 | 29.91 | -7.61 | 33.06 |
Change in Other Net Operating Assets | -5.74 | 8.45 | 75.55 | -0.45 | 1.51 |
Operating Cash Flow | -125.81 | 14.19 | 22.21 | 5.26 | 27.03 |
Operating Cash Flow Growth | - | -36.10% | 322.52% | -80.55% | 1612.03% |
Capital Expenditures | -24.08 | -8.62 | -26.1 | -18.23 | -39.67 |
Sale of Property, Plant & Equipment | 0.01 | - | - | - | - |
Investment in Securities | - | - | - | 0.1 | - |
Other Investing Activities | 9.07 | 0.7 | 0.83 | 1.25 | 0.03 |
Investing Cash Flow | -15 | -7.92 | -25.28 | -66.74 | -54.42 |
Short-Term Debt Issued | 241.82 | 3.8 | 16.28 | 7.88 | 9.92 |
Long-Term Debt Issued | - | 1.32 | 10.97 | - | 2.8 |
Total Debt Issued | 241.82 | 5.12 | 27.25 | 7.88 | 12.72 |
Long-Term Debt Repaid | -19.83 | - | - | -16.91 | - |
Total Debt Repaid | -19.83 | - | - | -16.91 | - |
Net Debt Issued (Repaid) | 221.99 | 5.12 | 27.25 | -9.03 | 12.72 |
Issuance of Common Stock | - | - | - | 83.76 | 27.09 |
Common Dividends Paid | - | -5.01 | - | - | -1.52 |
Other Financing Activities | -22.43 | -14.88 | -15.1 | -11.84 | -11.75 |
Financing Cash Flow | 199.56 | -14.77 | 12.15 | 62.89 | 26.54 |
Miscellaneous Cash Flow Adjustments | - | - | - | 0 | - |
Net Cash Flow | 58.75 | -8.51 | 9.09 | 1.41 | -0.85 |
Free Cash Flow | -149.89 | 5.57 | -3.89 | -12.97 | -12.64 |
Free Cash Flow Margin | -13.57% | 0.54% | -0.53% | -2.10% | -2.52% |
Free Cash Flow Per Share | -7.47 | 0.28 | -0.19 | -0.67 | -1.03 |
Cash Interest Paid | 22.43 | 14.88 | 15.1 | 11.84 | 11.76 |
Cash Income Tax Paid | 4.39 | 3.52 | 3.11 | 3.15 | 3.87 |
Levered Free Cash Flow | -218.94 | -68.33 | -36.06 | -100.53 | -157.48 |
Unlevered Free Cash Flow | -204.92 | -59.35 | -27.25 | -93.51 | -150.32 |
Change in Working Capital | -295.66 | -177.56 | -85.19 | -85.63 | -38.61 |